Theriva Biologics (TOVX) EPS (Basic) (2010 - 2026)
Theriva Biologics (TOVX) posted quarterly EPS (Basic) of -$0.05 for Q1 2026, up 96.8% year-over-year from -$0.03 in Q1 2025, and up 82.98% quarter-over-quarter from -$0.29 in Q4 2025.
Theriva Biologics (TOVX) EPS (Basic) (2010 - 2026) Analysis & Trends
Theriva Biologics (TOVX) has reported EPS (Basic) for 16 consecutive years, with -$0.05 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 96.8% year-over-year to -$0.05; the TTM figure through Mar 2026 stood at -$0.56 (up 93.69% YoY), while the FY2025 annual figure was -$2.08, up 89.07% from the prior year.
- EPS (Basic) improved to -$0.05 in Q1 2026 per TOVX's latest filing, from -$0.29 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.05 in Q1 2026 and bottomed at -$10.72 in Q2 2024.
- Historically, EPS (Basic) has averaged -$5.57 across 5 years, with a median of -$7.06 in 2022.
- Annual changes were most pronounced in 2024 — EPS (Basic) plunged 40.22% — and 2026, when it jumped 96.8%.
- Theriva Biologics' EPS (Basic) stood at -$10.48 in 2022, then grew by 19.3% to -$8.46 in 2023, then jumped by 61.0% to -$3.3 in 2024, then jumped by 91.14% to -$0.29 in 2025, then jumped by 82.98% to -$0.05 in 2026.
- Business Quant data shows TOVX's EPS (Basic) at -$0.05 in Q1 2026, -$0.29 in Q4 2025, and -$0.45 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.18 |
| 10 | Theriva Biologics | 11.01 Mn | 11.01 Mn | - | -0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.07 |
| Mar 31, 2026 | -0.05 |
| Dec 31, 2025 | -0.29 |
| Sep 30, 2025 | -0.45 |
| Jun 30, 2025 | -1.94 |
| Mar 31, 2025 | -1.55 |
| Dec 31, 2024 | -3.30 |
| Sep 30, 2024 | -6.79 |
| Jun 30, 2024 | -10.72 |
| Mar 31, 2024 | -7.58 |
| Dec 31, 2023 | -8.46 |
| Sep 30, 2023 | -4.84 |
| Jun 30, 2023 | -8.41 |
| Mar 31, 2023 | -7.40 |
| Dec 31, 2022 | -10.48 |
| Sep 30, 2022 | -7.62 |
| Jun 30, 2022 | -7.06 |
| Mar 31, 2022 | -7.73 |
| Dec 31, 2021 | -10.85 |
| Sep 30, 2021 | -6.25 |